Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125669811 | 12566981 | 1 | I | 201507 | 20160711 | 20160718 | 20160718 | EXP | PHHY2016IT096820 | NOVARTIS | 68.00 | YR | F | Y | 0.00000 | 20160718 | CN | COUNTRY NOT SPECIFIED | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125669811 | 12566981 | 1 | PS | OCTREOTIDE, LONG ACTING | OCTREOTIDE ACETATE | 1 | Unknown | 30 MG (EVERY 28 DAYS) | 21008 | 30 | MG | /month | |||||||
| 125669811 | 12566981 | 2 | SS | OCTREOTIDE, LONG ACTING | OCTREOTIDE ACETATE | 1 | Unknown | 30 MG (EVERY 21 DAYS) | 21008 | 30 | MG | ||||||||
| 125669811 | 12566981 | 3 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
| 125669811 | 12566981 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | AFTER ONE CYCLE OF THERAPY | 0 | ||||||||||
| 125669811 | 12566981 | 5 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | AFTER TWO CYCLE OF THERAPY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125669811 | 12566981 | 1 | Neuroendocrine tumour |
| 125669811 | 12566981 | 3 | Metastases to bone |
| 125669811 | 12566981 | 4 | Product used for unknown indication |
| 125669811 | 12566981 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125669811 | 12566981 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125669811 | 12566981 | Drug intolerance | |
| 125669811 | 12566981 | Hypersensitivity | |
| 125669811 | 12566981 | Inappropriate schedule of drug administration | |
| 125669811 | 12566981 | Malignant neoplasm progression | |
| 125669811 | 12566981 | Metastases to bone | |
| 125669811 | 12566981 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125669811 | 12566981 | 1 | 201505 | 0 | ||
| 125669811 | 12566981 | 3 | 201506 | 0 | ||
| 125669811 | 12566981 | 4 | 2016 | 0 | ||
| 125669811 | 12566981 | 5 | 2016 | 0 |